Funding   |   Policy Updates

FDA Announces Pilot for Orphan Designation Requests

ASGCT Staff - March 07, 2018

FDA Commissioner Scott Gottlieb, M.D. announced last week new actions the FDA is taking to support and expedite development of rare disease products, including a new pilot for more efficient orphan designation requests.

FDA Commissioner Scott Gottlieb, M.D. announced last week new actions the FDA is taking to support and expedite development of rare disease products, including a new pilot for more efficient orphan designation requests.

A new fillable form will ease the submission process for sponsors completing designation requests, and increase the efficiency of FDA review. The FDA also launched a new online tutorial to guide sponsors through the orphan designation process.

Related Articles

ASGCT News

Gene, Cell, & RNA Therapy Landscape: Q1 2021

David M. Barrett, J.D., M.S. - April 15, 2021
Policy Updates

FDA, NIH Issue Guidance on Conducting Clinical Trials During a Pandemic

ASGCT Staff - April 06, 2020
Policy Updates

ASGCT Applauds FDA's Gene Therapy Guidance Documents

Adora Ndu, PharmD, J.D. - February 03, 2020
Policy Updates

ASGCT Invited to Join USP as a Voting Member

ASGCT Staff - January 08, 2020